| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |